Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options	Chronic Pulmonary Aspergillosis	Active, not recruiting	Phase 2	2026-05-14		NCT06794554

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Mundipharma Research Limited	2

37 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Asklepios Lungenfachklinik Gauting	Gauting	Germany	1
Brussels University Hospital	Brussels	Belgium	1
Chonnam National University Hospital	Gwangju	South Korea	44
CHU Amiens Picardie	Amiens	France	31
CHU Arnaud de Villeneuve	Montpellier	France	4
Chu Bordeaux	Pessac	France	8
CHU UCL Namur	Yvoir	Belgium	3
Evangelische Lungenklinik Berlin	Berlin	Germany	6
Hospital de la Santa Creu i Sant Pau	Barcelona	Spain	64
Hospital La Fe	Valencia	Spain	9
Hospital Sant Joan de Deu de Martorell	Martorell	Spain	1
Hospital Universitari de Bellvitge	Barcelona	Spain	11
Humanitas Research Hospital	Rozzano	Italy	5
Imperial College Hospital	London	United Kingdom	1
INMI Lazzaro Spallanzaniconsu	Roma	Italy	1
Institut Coeur Poumon CHU	Lille	France	1
Kepler University Hospital	Linz	Austria	6
Leeds Teaching Hospital	Leeds	United Kingdom	2
Manchester University Hospital	Manchester	United Kingdom	2
Országos Korányi Pulmonológiai Intézet	Budapest	Hungary	2
Radboud Universitair Medisch Centrum Stichting	Nijmegen	Netherlands	1
Ramón y Cajal Hospital	Madrid	Spain	1
Royal Brompton Hospital, Guy's and St. Thomas' Hospital	London	United Kingdom	1
Royal Papworth Hospital	Cambridge	United Kingdom	18
Seoul National University Bundang Hospital	Seoul	South Korea	11

Clinical trials